Hinge Health, Inc.

NYSE:HNGE

Medical - Healthcare Information Services

Healthcare
$114.53 -0.36%

-$0.24 today

Market cap
$9.31B
Beta
1.99
P/E (TTM)
-10.3
EPS (TTM)
-$6.49
52W Low $30.08High $70.72

Volume 1.23M

Average 1.34M

HNGE Interest Expense

Cost of servicing the company's debt during the period.

Hinge Health, Inc.NYSE: HNGE

Interest Expense · Q2 FY2026 · quarter ended Jun 2026

Interest expense remains negative

Q2 FY2026 interest expense was $0, compared with $0 a year earlier. Trailing-twelve-month interest expense was $0.

Context

  • Interest expense amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Interest expense increased in 0 of the last 2 fiscal years.
  • FY2025 was the highest annual figure in the 3 fiscal years shown.

What to watch

Whether quarterly interest expense holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMJun 2026
$0— YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Interest Expense vs competitors

How HNGE compares with its peers on the latest reported figures

  • HNGE's LTM Jun 2026 interest expense of $0 is the lowest of the 5 companies compared; the peer median is $33.39M.
  • Interest expense amounts to 0.0% of revenue for HNGE, versus a peer median of 1.8%.
HNGE Competitors Peer median
Interest Expense for HNGE and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SNNSmith & Nephew plcFY2025$141.33M -5.8%+20.9%2.3%
ENOVEnovis CorporationLTM Apr 2026$56.8M +22.7%+11.8%2.5%
USPHU.S. Physical Therapy, Inc.LTM Mar 2026$9.97M +19.8%+17.9%1.4%
OMDAOmada HealthLTM Mar 2026$1.48M -66.8%-15.5%0.5%
HNGEHinge Health, Inc.LTM Jun 2026$0 ——0.0%
Peer median (excluding HNGE) $33.39M+7.0%+14.8%1.8%

Competitors are the stored peer set for HNGE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue292.73M390.4M587.86M
Cost of Revenue98.55M89.81M118.56M
Gross Profit194.18M300.59M469.3M
Gross Margin66.3%77.0%79.8%
Research & Development110.06M100.84M368.14M
Selling, General & Admin214.64M227.54M639.41M
Operating Expenses324.69M332.5M1.02B
Depreciation & Amortization5.63M5.95M5.13M
EBITDA(124.89M)(18.48M)(535.89M)
EBITDA Margin-42.7%-4.7%-91.2%
Operating Income(130.51M)(31.91M)(546.37M)
Operating Margin-44.6%-8.2%-92.9%
Interest Income000
Interest Expense000
Other Income / Expenses21.97M20.65M19.11M
Income Before Tax(108.55M)(11.26M)(527.26M)
Pre-Tax Margin-37.1%-2.9%-89.7%
Income Tax Expense(405K)677K998K
Net Income(108.14M)(11.93M)(528.26M)
Net Margin-36.9%-3.1%-89.9%
EPS (Basic)(1.39)(0.15)(5.36)
EPS (Diluted)(1.39)(0.15)(5.19)
Weighted Avg Shares78.02M78.02M79.19M
Weighted Avg Shares (Diluted)78.02M78.02M81.7M

Hinge Health, Inc.

NYSE:HNGE

Intrinsic Alpha fair value

Locked

Current Price

$114.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.